As a leading biopharma company, partnering is a key priority for us and plays a critical role in our strategy. We seek to combine external innovative science and technologies with our internal capabilities and expertise to transform patients’ lives through science. We are active across the entire business development spectrum and all our collaborations are essential to evolving our portfolio and driving our long-term sustainability.
SEND US A PARTNERING MEETING REQUEST
"We are open to a wide range of opportunities with prospective partners that will drive us towards groundbreaking healthcare solutions and help transform patients' lives through science."
Julie Rozenblyum
Senior Vice President, Business Development
Business Development Search & Evaluation
Benjamin Cohn
Associate Director, BD S&E
Harold Hatch
Associate Director, BD S&E
Yangzi He
Associate Director, BD S&E
Gaurav Shah
Director, BD S&E
Joseph Simeone
Executive Director, BD S&E
Kilang Yanger
Associate Director, BD S&E
Siying Zou
Associate Director, BD S&E
Business Development & Licensing Transactions
Michelle Li
Vice President, BD&L Transactions
Karen Martell
Senior Director, BD&L Transactions
Michael McInerney
Executive Director, BD&L Transactions
John Vandegrift
Director, BD&L Transactions
Global Alliances
Nisha Zaidi
Vice President, Global Alliances
Commercial Team
Victoria Ulrich
Vice President, WW Cardiovascular, Early Assets, Business Development & Strategy
Global Drug Development Team
Feng Bian
Executive Director, Integrative Sciences
Zarqa Mohammad
Sr. Dir, Clinical Evaluation & Collaborations, Immunology Development
Research Team
Roland Grenningloh
Executive Director, Integrative Sciences – Immunology